SARS-like cluster of circulating bat coronavirus pose threat for human emergenceThierry Debels
1) Researchers examined the disease potential of SARS-like coronaviruses currently circulating in Chinese horseshoe bat populations.
2) They generated a chimeric virus with the spike protein of a bat coronavirus (SHC014) inserted into a mouse-adapted SARS-CoV backbone.
3) Tests showed the chimeric virus could efficiently infect multiple species' ACE2 receptors, replicate in human airway cells, and cause lung infection and disease in mice, demonstrating its potential threat to humans.
The document discusses living organisms and infectious diseases. It provides multiple choice questions about topics like how malaria is transmitted (via the Anopheles mosquito), how athlete's foot spreads (via contact with fungus on surfaces), why viruses can only reproduce within hosts (they need host cells to replicate), examples of infectious diseases (influenza), and how scientists analyze data about epidemics/pandemics (using modeling, experiments, and clinical trials). It also covers questions about antibiotic treatment of diseases, microbial drug resistance, pandemic infections, preventing disease spread, benefits of biotechnology, related career fields, genetic modification of crops, and useful changes to crops from biotechnology like increased disease resistance.
In response to the recent Nipah virus outbreak in Kerala, I am posting a presentation I completed in May 2021. It provides an overview of the virus, where and how I think future outbreaks are likely to occur, its pandemic potential, and global health considerations to prevent and mitigate future outbreaks. Thanks for watching!
Science and technology has gone so far ahead. And it is still advancing at such a damn pace, that you
cannot imagine where it’s going to lead. But, yes its leading towards better solutions and results and no
doubt at the same time its leading to the hell lots of trouble too!. These outcomes from all research and
experiments do give some positive and negative aspects too. Positive solutions are always highlighted in
media and negative aspects and can be given a word as deadly negative solutions are kept hidden in labs
and in community among people.
Scientists have found evidence that the coronavirus may be mutating and adapting to humans. Analysis of over 5,300 coronavirus genomes from around the world showed that some strains have gained mutations in the spike protein that the virus uses to infect cells. While the mutations are still rare, they arose independently in different countries and may help the virus spread more easily. Scientists are concerned that more extensive mutations could impact the effectiveness of potential vaccines and treatments being developed that target the spike protein. Ongoing surveillance is needed to monitor any changes in the virus.
The document summarizes information about MRSA (Methicillin-resistant Staphylococcus aureus) from multiple sources. It defines MRSA as a mutated form of staph bacteria that has become resistant to many antibiotics. The document outlines the symptoms of MRSA infection including boils and abscesses. It also discusses how MRSA interacts with and spreads within the human body. Prevention methods like hand washing and avoiding sharing personal items are mentioned. Current treatments involve antibiotics like vancomycin, though developing an effective vaccine remains a challenge.
There have been a few reported cases where individuals were infected with HIV but then eliminated the virus from their body after a year or two with no detectable virus. Some experts believe these individuals may have succeeded in curing their HIV infection. Certain genes may provide some people with natural protection against HIV. By studying these genes, researchers hope to find ways to protect others. Some individuals exposed to HIV show signs of immune response to the virus but do not become infected, suggesting their immune system eliminated the virus upon exposure. Many people may have the ability to destroy a limited number of HIV particles, preventing infection from small exposures.
SARS-like cluster of circulating bat coronavirus pose threat for human emergenceThierry Debels
1) Researchers examined the disease potential of SARS-like coronaviruses currently circulating in Chinese horseshoe bat populations.
2) They generated a chimeric virus with the spike protein of a bat coronavirus (SHC014) inserted into a mouse-adapted SARS-CoV backbone.
3) Tests showed the chimeric virus could efficiently infect multiple species' ACE2 receptors, replicate in human airway cells, and cause lung infection and disease in mice, demonstrating its potential threat to humans.
The document discusses living organisms and infectious diseases. It provides multiple choice questions about topics like how malaria is transmitted (via the Anopheles mosquito), how athlete's foot spreads (via contact with fungus on surfaces), why viruses can only reproduce within hosts (they need host cells to replicate), examples of infectious diseases (influenza), and how scientists analyze data about epidemics/pandemics (using modeling, experiments, and clinical trials). It also covers questions about antibiotic treatment of diseases, microbial drug resistance, pandemic infections, preventing disease spread, benefits of biotechnology, related career fields, genetic modification of crops, and useful changes to crops from biotechnology like increased disease resistance.
In response to the recent Nipah virus outbreak in Kerala, I am posting a presentation I completed in May 2021. It provides an overview of the virus, where and how I think future outbreaks are likely to occur, its pandemic potential, and global health considerations to prevent and mitigate future outbreaks. Thanks for watching!
Science and technology has gone so far ahead. And it is still advancing at such a damn pace, that you
cannot imagine where it’s going to lead. But, yes its leading towards better solutions and results and no
doubt at the same time its leading to the hell lots of trouble too!. These outcomes from all research and
experiments do give some positive and negative aspects too. Positive solutions are always highlighted in
media and negative aspects and can be given a word as deadly negative solutions are kept hidden in labs
and in community among people.
Scientists have found evidence that the coronavirus may be mutating and adapting to humans. Analysis of over 5,300 coronavirus genomes from around the world showed that some strains have gained mutations in the spike protein that the virus uses to infect cells. While the mutations are still rare, they arose independently in different countries and may help the virus spread more easily. Scientists are concerned that more extensive mutations could impact the effectiveness of potential vaccines and treatments being developed that target the spike protein. Ongoing surveillance is needed to monitor any changes in the virus.
The document summarizes information about MRSA (Methicillin-resistant Staphylococcus aureus) from multiple sources. It defines MRSA as a mutated form of staph bacteria that has become resistant to many antibiotics. The document outlines the symptoms of MRSA infection including boils and abscesses. It also discusses how MRSA interacts with and spreads within the human body. Prevention methods like hand washing and avoiding sharing personal items are mentioned. Current treatments involve antibiotics like vancomycin, though developing an effective vaccine remains a challenge.
There have been a few reported cases where individuals were infected with HIV but then eliminated the virus from their body after a year or two with no detectable virus. Some experts believe these individuals may have succeeded in curing their HIV infection. Certain genes may provide some people with natural protection against HIV. By studying these genes, researchers hope to find ways to protect others. Some individuals exposed to HIV show signs of immune response to the virus but do not become infected, suggesting their immune system eliminated the virus upon exposure. Many people may have the ability to destroy a limited number of HIV particles, preventing infection from small exposures.
Interpreting genomic variation and phylogenetic trees to understand disease t...Jennifer Gardy
The document discusses using genomic sequencing data and phylogenetic trees to understand disease transmission. It provides an example of using whole genome sequencing to determine that multiple tuberculosis isolates showing identical molecular typing patterns were the result of laboratory contamination rather than transmission. The importance of high quality sequencing data and appropriate bioinformatics analysis is emphasized. Methods for manually inferring transmission by examining mutation patterns in isolates in the context of epidemiological data are described. Mathematical approaches that use phylogenetic trees to probabilistically infer transmission are also discussed.
This document contains press releases from three different studies:
1. A study finding that a bacterial molecule can train the immune system to tolerate infection without causing illness. This was reported by multiple news sources.
2. A study identifying anti-infective compounds from bacteria that could interrupt acute and persistent infections. This led to the founding of Spero Therapeutics.
3. A study identifying factors that can predict risk of multiple infections in patients with severe burns. This was also reported by multiple medical and science news organizations.
From Discovery to Delivery: Benchwork to Global Health: Jerry CangelosiUWGlobalHealth
Explores relationships and discrepancies between important research-based medical advancements and subsequent real world implementation. Advancements in the management and potential elimination of infectious diseases such as HIV and TB will be addressed, as related to development and implementation of effective diagnostics, vaccines, or treatments.
SMBE Satellite Meeting on Pathogen Evolution and TransmissionJennifer Gardy
This document discusses the use of genomics in public health tuberculosis (TB) research and outlines key studies and findings over time. It begins with early work in 2008-2010 sequencing 36 genomes from a Port Alberni outbreak to understand transmission. From 2011-2013, 40-52 genomes were analyzed from a Kelowna outbreak to infer transmission patterns and evaluate outbreak control strategies. A later study sequenced over 276 genomes from Vancouver from 2005-2014 to analyze TB epidemiology and trends in British Columbia. Ongoing work aims to use genomics to rapidly detect drug resistance for improved diagnosis and outbreak detection, including analyzing suspected lab contamination events. The field continues advancing with new techniques to study rare variants with the goal of sequencing over 750 TB
This document discusses how genomics is revolutionizing public health microbiology. It provides three examples:
1) Rapid WGS-based diagnosis identified Leptospira bacteria in a patient's cerebrospinal fluid, allowing targeted penicillin treatment that resolved his illness within two weeks.
2) WGS-based drug sensitivity testing allows personalized therapy by predicting resistance from a pathogen's genome within 1 day, compared to weeks for conventional methods.
3) Genomic epidemiology tracks person-to-person disease spread by comparing whole genomes from outbreak isolates. This approach helped determine the key locations and time period fueling a TB outbreak in BC, and later demonstrated transmission had ended.
This lesson plan aims to teach students about acquired immune deficiency syndrome (AIDS) through a journey inside the human body. It explains how HIV infects and destroys T-cells, remaining dormant in the body for years before developing into AIDS. HIV is transmitted through sexual intercourse, blood contact, or from mother to child during birth or breastfeeding. An assessment activity involves students sorting cards listing risk factors and non-risk factors for HIV transmission. A follow-up debate could discuss AIDS education and policies around needle exchange, testing, and condom use.
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...ILRI
Poster prepared Joseph Ogola, Hussein Alburkat, Moses Masika, Essi Korhonen, Ruut Uusitalo, Philip Nyaga, Omu Anzala, Olli Vapalahti, Tarja Sironen and Kristian M. Forbes for the Kenya One Health Online Conference, 6-8 December 2021
early strategies in HIV infection and nurses role. In this the nurses should understand the strategies in diagnosing HIV and management along with nursing care. So that nurses can alleviate the patients problems and relieve the problems based on different strategies
Kaisar Ali Molla, a class 12 student, conducted a biology project on Acquired Immunodeficiency Syndrome (AIDS) under the guidance of his teacher Ms. Laxmi Rai. The project discusses the causes of AIDS, its symptoms, diagnosis, treatment and prevention. It details how HIV attacks and weakens the immune system, making one vulnerable to opportunistic infections. While there is no cure for AIDS, early testing and treatment can slow its progression and increase quality of life. The student concludes that ignorance and lack of knowledge are major factors fueling the spread of this disease.
Lyme disease is a pandemic that is often misdiagnosed and inadequately treated due to political and financial factors according to the author. There are multiple species of Borrelia bacteria that cause Lyme disease worldwide, but diagnostic tests and treatment regimens are primarily designed for just one species found in North America. This has led to many false negatives and chronic, persistent infections when treatment fails. The evidence suggests Lyme disease may be linked to other serious conditions like Alzheimer's, but this information has been ignored. A vaccine was produced but caused autoimmune issues in some people due to molecular mimicry between the vaccine and human proteins. Overall the author argues Lyme disease is a major global problem that is being under addressed
The document provides a resume for Sandra Sharpe Cohen detailing her extensive experience in virology and immunology research since 1980, including her current role as Assistant Research Scientist at NYU School of Medicine since 1999. It outlines her responsibilities in areas such as research project design, data analysis, assay development, and supervision of lab personnel. Her education and skills in various laboratory techniques are also summarized.
This document is a history of medicine project on the treatment of AIDS. It discusses how AIDS was first reported in 1981 and has since killed over 25 million people. It is caused by the HIV virus. The document then covers the stages of HIV infection and treatment options for AIDS including highly active antiretroviral therapy (HAART), immunotherapy, and stem cell therapy. However, it notes that there is currently no permanent cure for AIDS due to the high mutability of the HIV virus.
This document summarizes research on the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document discusses how AAV is being used experimentally to treat diseases like cystic fibrosis, cancer, and heart disease by delivering therapeutic genes. While challenges remain, AAV vectors appear safer than other methods and have the potential to treat many currently incurable diseases.
Aa Vin The Treatment Of Human DiseasesReginaDGates
This document discusses the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document focuses on how AAV may be used as a therapy for cystic fibrosis, cancer, and heart disease. It summarizes challenges with AAV therapy but concludes that AAV vectors appear to be among the safest methodologies for further developing therapies for many currently incurable diseases.
This document provides information about HIV/AIDS, including its causes, symptoms, diagnosis, and treatment. It discusses how HIV weakens the immune system and can lead to AIDS if untreated. The document outlines how HIV is transmitted, the stages of HIV infection from early to late stage AIDS, and how HIV is diagnosed through blood tests. It discusses the current treatments for HIV like antiretroviral drugs and pre-exposure prophylaxis, as well as recent developments in treatments and efforts towards developing a vaccine.
HIV stands for Human Immunodeficiency Virus. It weakens a person's immune system by destroying white blood cells, making the body vulnerable to other infections and diseases. HIV is transmitted through unprotected sex, sharing needles, unsafe blood transfusions, and from mother to child during pregnancy, childbirth or breastfeeding. While some people experience flu-like symptoms shortly after infection, many live asymptomatic for years before developing AIDS. There is no vaccine or cure for HIV/AIDS, so prevention through safe sex practices and access to treatment are important.
The document provides information about HIV/AIDS, including:
1) It describes what HIV and AIDS are, how HIV causes AIDS by compromising the immune system over time.
2) It provides statistics on HIV infections in the US since 1981, including that 1 in 5 people living with HIV are unaware of their status.
3) It summarizes research showing that HIV likely originated from transmission from chimpanzees to humans in the early 20th century.
4) It lists symptoms that can emerge when HIV progresses to AIDS and compromises the immune system.
Discuss any five myths associated with HIV and AidsFarai Mushangwe
The document discusses five common myths associated with HIV/AIDS and how they can be demystified. The myths are: 1) AIDS only affects homosexual men and drug users; 2) AIDS can be transmitted through casual contact or insect bites; 3) older people do not get AIDS; 4) AIDS is always fatal; 5) HIV-positive women should not have children. Each myth is explained as factually incorrect by providing evidence about how HIV/AIDS can affect anyone and is transmitted only through specific body fluids, not casual contact or insects, and that medication can now prevent mother-to-child transmission and prolong life for those infected.
Sorry this presentation is not great, because all the animations just stockpiled. If you want to see a better version, please go to http://tinyurl.com/pat48ks
Thanks!
The document discusses the potential benefits of introducing at-home HIV testing kits in Indonesia. It notes that Indonesia has a rapidly growing HIV epidemic, with over 500,000 new infections projected in 2014 if prevention programs are not accelerated. Currently, HIV testing is only available at hospitals through voluntary counseling and testing clinics, requiring patients to visit. At-home testing kits could increase access to testing by allowing people to test at home privately. However, there are also concerns about the accuracy of at-home tests and the lack of in-person counseling that occurs with clinic-based testing. Studies have found that telephone counseling provided with at-home kits can be an effective alternative to in-person counseling.
AIDS was first reported in 1981 and has since killed over 25 million people worldwide. It is caused by the HIV virus, which was likely transmitted to humans from chimpanzees in Central Africa. HIV targets and destroys CD4+ T cells of the immune system, ultimately weakening the body's ability to fight infections and disease. While drug cocktails can suppress HIV and prolong life, there is currently no cure as the virus is highly mutable and exhibits frequent antigenic variations. Researchers are exploring immunotherapy and stem cell gene therapy approaches to achieve a permanent cure for AIDS.
Dr. Stephanie Rossow - Applications of Next Generation SequencingJohn Blue
Applications of Next Generation Sequencing - Dr. Stephanie Rossow, College of Veterinary Medicine, University of Minnesota, from the 2016 Allen D. Leman Swine Conference, September 17-20, 2016, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2016-leman-swine-conference-material
Interpreting genomic variation and phylogenetic trees to understand disease t...Jennifer Gardy
The document discusses using genomic sequencing data and phylogenetic trees to understand disease transmission. It provides an example of using whole genome sequencing to determine that multiple tuberculosis isolates showing identical molecular typing patterns were the result of laboratory contamination rather than transmission. The importance of high quality sequencing data and appropriate bioinformatics analysis is emphasized. Methods for manually inferring transmission by examining mutation patterns in isolates in the context of epidemiological data are described. Mathematical approaches that use phylogenetic trees to probabilistically infer transmission are also discussed.
This document contains press releases from three different studies:
1. A study finding that a bacterial molecule can train the immune system to tolerate infection without causing illness. This was reported by multiple news sources.
2. A study identifying anti-infective compounds from bacteria that could interrupt acute and persistent infections. This led to the founding of Spero Therapeutics.
3. A study identifying factors that can predict risk of multiple infections in patients with severe burns. This was also reported by multiple medical and science news organizations.
From Discovery to Delivery: Benchwork to Global Health: Jerry CangelosiUWGlobalHealth
Explores relationships and discrepancies between important research-based medical advancements and subsequent real world implementation. Advancements in the management and potential elimination of infectious diseases such as HIV and TB will be addressed, as related to development and implementation of effective diagnostics, vaccines, or treatments.
SMBE Satellite Meeting on Pathogen Evolution and TransmissionJennifer Gardy
This document discusses the use of genomics in public health tuberculosis (TB) research and outlines key studies and findings over time. It begins with early work in 2008-2010 sequencing 36 genomes from a Port Alberni outbreak to understand transmission. From 2011-2013, 40-52 genomes were analyzed from a Kelowna outbreak to infer transmission patterns and evaluate outbreak control strategies. A later study sequenced over 276 genomes from Vancouver from 2005-2014 to analyze TB epidemiology and trends in British Columbia. Ongoing work aims to use genomics to rapidly detect drug resistance for improved diagnosis and outbreak detection, including analyzing suspected lab contamination events. The field continues advancing with new techniques to study rare variants with the goal of sequencing over 750 TB
This document discusses how genomics is revolutionizing public health microbiology. It provides three examples:
1) Rapid WGS-based diagnosis identified Leptospira bacteria in a patient's cerebrospinal fluid, allowing targeted penicillin treatment that resolved his illness within two weeks.
2) WGS-based drug sensitivity testing allows personalized therapy by predicting resistance from a pathogen's genome within 1 day, compared to weeks for conventional methods.
3) Genomic epidemiology tracks person-to-person disease spread by comparing whole genomes from outbreak isolates. This approach helped determine the key locations and time period fueling a TB outbreak in BC, and later demonstrated transmission had ended.
This lesson plan aims to teach students about acquired immune deficiency syndrome (AIDS) through a journey inside the human body. It explains how HIV infects and destroys T-cells, remaining dormant in the body for years before developing into AIDS. HIV is transmitted through sexual intercourse, blood contact, or from mother to child during birth or breastfeeding. An assessment activity involves students sorting cards listing risk factors and non-risk factors for HIV transmission. A follow-up debate could discuss AIDS education and policies around needle exchange, testing, and condom use.
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...ILRI
Poster prepared Joseph Ogola, Hussein Alburkat, Moses Masika, Essi Korhonen, Ruut Uusitalo, Philip Nyaga, Omu Anzala, Olli Vapalahti, Tarja Sironen and Kristian M. Forbes for the Kenya One Health Online Conference, 6-8 December 2021
early strategies in HIV infection and nurses role. In this the nurses should understand the strategies in diagnosing HIV and management along with nursing care. So that nurses can alleviate the patients problems and relieve the problems based on different strategies
Kaisar Ali Molla, a class 12 student, conducted a biology project on Acquired Immunodeficiency Syndrome (AIDS) under the guidance of his teacher Ms. Laxmi Rai. The project discusses the causes of AIDS, its symptoms, diagnosis, treatment and prevention. It details how HIV attacks and weakens the immune system, making one vulnerable to opportunistic infections. While there is no cure for AIDS, early testing and treatment can slow its progression and increase quality of life. The student concludes that ignorance and lack of knowledge are major factors fueling the spread of this disease.
Lyme disease is a pandemic that is often misdiagnosed and inadequately treated due to political and financial factors according to the author. There are multiple species of Borrelia bacteria that cause Lyme disease worldwide, but diagnostic tests and treatment regimens are primarily designed for just one species found in North America. This has led to many false negatives and chronic, persistent infections when treatment fails. The evidence suggests Lyme disease may be linked to other serious conditions like Alzheimer's, but this information has been ignored. A vaccine was produced but caused autoimmune issues in some people due to molecular mimicry between the vaccine and human proteins. Overall the author argues Lyme disease is a major global problem that is being under addressed
The document provides a resume for Sandra Sharpe Cohen detailing her extensive experience in virology and immunology research since 1980, including her current role as Assistant Research Scientist at NYU School of Medicine since 1999. It outlines her responsibilities in areas such as research project design, data analysis, assay development, and supervision of lab personnel. Her education and skills in various laboratory techniques are also summarized.
This document is a history of medicine project on the treatment of AIDS. It discusses how AIDS was first reported in 1981 and has since killed over 25 million people. It is caused by the HIV virus. The document then covers the stages of HIV infection and treatment options for AIDS including highly active antiretroviral therapy (HAART), immunotherapy, and stem cell therapy. However, it notes that there is currently no permanent cure for AIDS due to the high mutability of the HIV virus.
This document summarizes research on the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document discusses how AAV is being used experimentally to treat diseases like cystic fibrosis, cancer, and heart disease by delivering therapeutic genes. While challenges remain, AAV vectors appear safer than other methods and have the potential to treat many currently incurable diseases.
Aa Vin The Treatment Of Human DiseasesReginaDGates
This document discusses the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document focuses on how AAV may be used as a therapy for cystic fibrosis, cancer, and heart disease. It summarizes challenges with AAV therapy but concludes that AAV vectors appear to be among the safest methodologies for further developing therapies for many currently incurable diseases.
This document provides information about HIV/AIDS, including its causes, symptoms, diagnosis, and treatment. It discusses how HIV weakens the immune system and can lead to AIDS if untreated. The document outlines how HIV is transmitted, the stages of HIV infection from early to late stage AIDS, and how HIV is diagnosed through blood tests. It discusses the current treatments for HIV like antiretroviral drugs and pre-exposure prophylaxis, as well as recent developments in treatments and efforts towards developing a vaccine.
HIV stands for Human Immunodeficiency Virus. It weakens a person's immune system by destroying white blood cells, making the body vulnerable to other infections and diseases. HIV is transmitted through unprotected sex, sharing needles, unsafe blood transfusions, and from mother to child during pregnancy, childbirth or breastfeeding. While some people experience flu-like symptoms shortly after infection, many live asymptomatic for years before developing AIDS. There is no vaccine or cure for HIV/AIDS, so prevention through safe sex practices and access to treatment are important.
The document provides information about HIV/AIDS, including:
1) It describes what HIV and AIDS are, how HIV causes AIDS by compromising the immune system over time.
2) It provides statistics on HIV infections in the US since 1981, including that 1 in 5 people living with HIV are unaware of their status.
3) It summarizes research showing that HIV likely originated from transmission from chimpanzees to humans in the early 20th century.
4) It lists symptoms that can emerge when HIV progresses to AIDS and compromises the immune system.
Discuss any five myths associated with HIV and AidsFarai Mushangwe
The document discusses five common myths associated with HIV/AIDS and how they can be demystified. The myths are: 1) AIDS only affects homosexual men and drug users; 2) AIDS can be transmitted through casual contact or insect bites; 3) older people do not get AIDS; 4) AIDS is always fatal; 5) HIV-positive women should not have children. Each myth is explained as factually incorrect by providing evidence about how HIV/AIDS can affect anyone and is transmitted only through specific body fluids, not casual contact or insects, and that medication can now prevent mother-to-child transmission and prolong life for those infected.
Sorry this presentation is not great, because all the animations just stockpiled. If you want to see a better version, please go to http://tinyurl.com/pat48ks
Thanks!
The document discusses the potential benefits of introducing at-home HIV testing kits in Indonesia. It notes that Indonesia has a rapidly growing HIV epidemic, with over 500,000 new infections projected in 2014 if prevention programs are not accelerated. Currently, HIV testing is only available at hospitals through voluntary counseling and testing clinics, requiring patients to visit. At-home testing kits could increase access to testing by allowing people to test at home privately. However, there are also concerns about the accuracy of at-home tests and the lack of in-person counseling that occurs with clinic-based testing. Studies have found that telephone counseling provided with at-home kits can be an effective alternative to in-person counseling.
AIDS was first reported in 1981 and has since killed over 25 million people worldwide. It is caused by the HIV virus, which was likely transmitted to humans from chimpanzees in Central Africa. HIV targets and destroys CD4+ T cells of the immune system, ultimately weakening the body's ability to fight infections and disease. While drug cocktails can suppress HIV and prolong life, there is currently no cure as the virus is highly mutable and exhibits frequent antigenic variations. Researchers are exploring immunotherapy and stem cell gene therapy approaches to achieve a permanent cure for AIDS.
Dr. Stephanie Rossow - Applications of Next Generation SequencingJohn Blue
Applications of Next Generation Sequencing - Dr. Stephanie Rossow, College of Veterinary Medicine, University of Minnesota, from the 2016 Allen D. Leman Swine Conference, September 17-20, 2016, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2016-leman-swine-conference-material
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) are described. HIV attacks immune cells and over time overwhelms the immune system, leading to AIDS. There are no cures for HIV or AIDS but antiretroviral therapy can slow disease progression and reduce transmission risk. Common symptoms in men include body rash, fever, sore throat and headaches, while in women symptoms include diarrhea, nausea, weight loss and shortness of breath. Nursing care focuses on preventing infection, maintaining nutrition, and managing symptoms.
The document provides an overview of HIV/AIDS, including its history, origin, life cycle, types, statistics, transmission, prevention, and treatment. It begins with definitions of HIV/AIDS, noting it attacks CD4 cells and destroys the immune system. It then discusses the early origins and identification of AIDS in the 1980s and various theories for the origin of HIV. It provides details on the life cycle and types of HIV viruses. Statistics on global prevalence and transmission methods like unprotected sex, needle sharing, and mother-to-child are presented. The document concludes with sections on prevention, treatment, and ICTC centers.
HIV is a retrovirus that causes AIDS by destroying CD4+ T cells and weakening the immune system. It is spherical in structure and contains two copies of RNA along with enzymes. HIV infection occurs through bodily fluids and replicates by reverse transcribing its RNA into DNA. There is no cure for HIV/AIDS but treatment can suppress the virus and prevent transmission through condom use, pre-exposure prophylaxis, testing and treatment of partners, and needle exchange programs.
Acquired Immunodeficiency Syndrome is severe HIV infection.
There were 940,000 deaths from AIDS in 2017.
Lancet estimated that global incidence of HIV infection peaked in 1997 at 3.3 million/year.
Similar to Animal vaccine study yields insights that may advance HIV vaccine research (20)
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Cell Therapy Expansion and Challenges in Autoimmune Disease
Animal vaccine study yields insights that may advance HIV vaccine research
1. st dt ips.co m
http://stdtips.co m/animal-vaccine-study-yields-insights-that-may-advance-hiv-vaccine-research/
Animal vaccine study yields insights that may advance HIV
vaccine research
STD Tips
January 14, 2014
Dec. 15, 2013 — A shot study in apes designed to identif y signif icant signs that the canines
were protected af ter inf ection by SIV, the monkey release of HIV, in addition to mechanism
of sort of protection has exhibited numerous insights that could perhaps advance HIV shot
research. Seven labs collaborated on the be trained in led by Mario Roederer, Ph. Def ense.,
and John N. Mascola, M. Def ense., at the Vaccine Search Center of the Country Institute of A
new and Inf ectious Disorders (NIAID), part of the Country Institutes of Body.
By examining these viral amino-acid sequences and the animals’ body’s def ense mechanisms responses,
the researchers could determine unquestionably the mechanisms of protection against SIV inf ection. Your
research demonstrated that antibodies inside the virus spikes your SIV uses so that you inf ect cells are
essential and suf f icient in order to SIV inf ection. Your research also identif ied lucid measures of body’s
def ense mechanisms responses in apes that predict protection against SIV inf ection.
Amid unquestionably the genetically heterogeneous mixture SIV to which unquestionably the vaccinated
monkeys they were exposed, vaccine-induced body’s def ense mechanisms responses tended to dam
inf ection by those particular viruses sensitive so that you neutralization by SIV antibodies, while
neutralization-resistant f orms of SIV were known to cause f ungal inf ection. A two-amino-acid in order to
the spikes onto SIV converted neutralization-sensitive SIV to neutralization-resistant SIV, and the other
way round. A similar change to unquestionably the spikes on HIV had a related appearance. T hus, SIV as
well as HIV escape immune system in similar tips, the scientists stumbled upon. T hey concluded that why
f uture human HIV vaccine trials collapse or succeed might be clearer if researchers integrate inf ormation on
unquestionably the amino-acid sequence as well as neutralization sensitivity or a resistance of the slowing
down virus together with the inf ormatioin needed f or volunteers’ immune results to the vaccine.
Share this thing on Facebook , Twitter , and Google :
Other social bookmarking as well as sharing tools:
Story Cause:
The above thing is based on products made available from NIH/National Institute pointing to
Allergy and Transmittable Diseases .
Lappen (derb): Materials may be modified for content as well as length. For further important
information, please contact the origin cited above.
Website Reference :
2. 1. Mario Roederer, Brandon Fahrenheit (f ). Keele, Stephen Def ense. Schmidt, Rosemarie Def ense.
Mason, Hugh Vitamins. Welles, Will Fischer, Celia Labranche, Kathryn E. Foulds, Stamp K. Louder, Z hiYong Yang, John-Paul B. Todd, Adam G. Buzby, Linh Versus. Mach, Ling Shen, Kelly E. Seaton, Brandy
M. Inf irmary, Robert T. Bailer, Raphael Gottardo, Wenjuan Gu, Guido Ferrari, S. Munir Alam, T homas N.
Denny, David C. Montef iori, Georgia D. Tomaras, Bette T. Korber, Martha C. Nason, Robert A. Seder,
Richard A. Koup, Norman L. Letvin, Srinivas S. Rao, Gary J. Nabel, John R. Mascola. Immunological
and virological accessories of vaccine-mediated prevention of SIV and HIV . Nature , 2013;
DOI: $18. 1038/nature12893 f riction material
Note: Where no author has, the source is offered instead.
Hi and thanks f or visiting my blog. I am Emilia W. Crane. As a f uture gynecologist I am very
concerned about increasing level of people inf ected with sexually transmitted diseases and
low level of young people education in this f ield. So, in my blog I am trying to collect all usef ul
inf ormation about prevention, symptoms, testing and treatment of stds. If you f eel anything
should be added to the site or want to get more inf ormation on some topic, please f eel f ree
to contact me via Facebook or Google+.